| scholarly article | Q13442814 |
| P50 | author | Josée Dupuis | Q29840575 |
| Sila Kurugol | Q84510796 | ||
| Rail San José Estépar | Q85108616 | ||
| P2093 | author name string | Wei Gao | |
| David A Schwartz | |||
| George R Washko | |||
| George T O'Connor | |||
| Jeanne C Latourelle | |||
| Hiroto Hatabu | |||
| Gary M Hunninghake | |||
| Ivan O Rosas | |||
| Mizuki Nishino | |||
| James C Ross | |||
| Oscar E Zazueta | |||
| Tetsuro Araki | |||
| Rachel K Putman | |||
| P2860 | cites work | The natural history of chronic airflow obstruction | Q24674578 |
| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis | Q28240230 | ||
| A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis | Q28240241 | ||
| Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis | Q28291143 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study | Q30790513 | ||
| Testing for genetic association taking into account phenotypic information of relatives | Q33519246 | ||
| Genetics and early detection in idiopathic pulmonary fibrosis | Q34479395 | ||
| Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation | Q34635121 | ||
| Lung volumes and emphysema in smokers with interstitial lung abnormalities | Q34781472 | ||
| Anterior Mediastinal Masses in the Framingham Heart Study: Prevalence and CT Image Characteristics | Q35094671 | ||
| ??? | Q28215495 | ||
| Interstitial lung abnormalities and reduced exercise capacity | Q35889148 | ||
| A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
| High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia | Q36447397 | ||
| Association Between Interstitial Lung Abnormalities and All-Cause Mortality | Q36790758 | ||
| Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance? | Q36844372 | ||
| Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate | Q37039525 | ||
| MUC5B promoter polymorphism and interstitial lung abnormalities | Q37105760 | ||
| Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. | Q37343777 | ||
| The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination | Q57072992 | ||
| Interstitial lung diseases in a lung cancer screening trial | Q57559323 | ||
| An investigation of coronary heart disease in families. The Framingham offspring study | Q59461737 | ||
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| The radiological patterns of interstitial change at an early phase: over a 4-year follow-up | Q84385516 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1514-1522 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study | |
| P478 | volume | 194 |
| Q47687005 | Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study |
| Q92482422 | Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study |
| Q38669356 | An Ounce of Prevention… Will This Be the Future for IPF? |
| Q89021536 | Assessment of Interstitial Lung Disease Using Lung Ultrasound Surface Wave Elastography: A Novel Technique With Clinicoradiologic Correlates |
| Q90746043 | CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis |
| Q54213046 | Clinical Genetics in Interstitial Lung Disease. |
| Q38785085 | Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. |
| Q90405941 | Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung Disease |
| Q89503712 | Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial ILD |
| Q89727423 | Dissecting the role of the small airways in idiopathic pulmonary fibrosis |
| Q48037972 | Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis |
| Q42367959 | Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment |
| Q40160454 | High Attenuation Areas on Chest CT and Clinical Respiratory Outcomes in Community-dwelling Adults. |
| Q49961512 | Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections |
| Q93091814 | Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways |
| Q38821078 | Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways |
| Q89691744 | Idiopathic pulmonary fibrosis |
| Q38656653 | Imaging approaches to understand disease complexity: Chronic Obstructive Pulmonary Disease as a clinical model |
| Q89936679 | Imaging research in fibrotic lung disease; applying deep learning to unsolved problems |
| Q57787416 | Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD |
| Q90447926 | Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis |
| Q90435776 | Increased respiratory morbidity in individuals with interstitial lung abnormalities |
| Q59332980 | Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis |
| Q97568165 | Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society |
| Q64232728 | Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis |
| Q92763554 | Interstitial lung abnormalities: ignotum per ignotius |
| Q49203047 | Interstitial lung abnormalities: risk and opportunity |
| Q64101872 | Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome |
| Q88235643 | Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement |
| Q92743108 | Looking at the Airway to Understand Interstitial Lung Disease |
| Q92186318 | Lower levels of α-Klotho in serum are associated with decreased lung function in individuals with interstitial lung abnormalities |
| Q90316654 | MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis |
| Q60044254 | Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice |
| Q40104303 | Occupational Exposures and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Air- Lung Study. |
| Q64053962 | Preserved Ratio Impaired Spirometry and Interstitial Lung Abnormalities in Smokers |
| Q91614581 | Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer |
| Q38995612 | Pulmonary fibrosis in the era of stratified medicine. |
| Q40272697 | Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis |
| Q64053951 | Reply to Marruchella: Preserved Ratio Impaired Spirometry and Interstitial Lung Abnormalities in Smokers |
| Q89182482 | Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q47679256 | Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings |
| Q37559937 | Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis? |
| Q47124422 | The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes |
| Q33924950 | The diagnosis of idiopathic pulmonary fibrosis: current and future approaches |
| Q47167193 | The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study |
| Q50056514 | Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? |
| Q39040828 | Tissue remodelling in pulmonary fibrosis |
| Q92620455 | Toward Early Detection of Idiopathic Pulmonary Fibrosis |
| Q48088026 | Toward Early Identification of Clinically Relevant Interstitial Lung Disease |
| Q91622811 | Translational research in pulmonary fibrosis |
| Q87909968 | Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography |
| Q49734357 | Update in Interstitial Lung Disease 2016. |
Search more.